Technology | Ultrasound Imaging | July 09, 2018

Healcerion Receives FDA Approval for Sonon 300L Handheld Ultrasound Device

App-based mobile ultrasound system provides flexible ultrasound technology for primary care providers

Healcerion Receives FDA Approval for Sonon 300L Handheld Ultrasound Device

July 9, 2018 — South Korea-based Healcerion launched the Sonon 300L wireless handheld ultrasound device to the U.S. market following U.S. Food and Drug Administration (FDA) approval. The Sonon 300L is designed to help primary care providers (PCPs) be more efficient and effective, with instant insight to diagnose or refer a patient to a specialist. The system  provides flexible ultrasound technology at less than 1/10 the cost of a traditional ultrasound machine, with a user interface anyone can learn in minutes, according to the company.

Sonon 300L is an advanced diagnostic imaging device that can be used anywhere, with a mobile app downloaded from the Google Play or Apple App Store.

The system also supports medical imaging protocols including DICOM (Digital Imaging and Communications in Medicine) and PACS (picture archiving and communication systems). Using intuitive finger-touch control to operate, it provides rapid, accurate diagnostics to improve patient care and improve efficiency. Sonon 300L has a three-hour continuous scanning battery life, which far exceeds other handheld ultrasound devices, according to Healcerion.

Currently, according to the February 2018 Journal of Family Practice, less than 10 percent of PCPs in the United States utilize ultrasound technology for diagnostic use - for example to assess thyroid, carotid, breast, lung and vascular conditions. In other countries, a larger percentage of physicians utilize diagnostic ultrasound in primary care.

Sonon 300L also provides a new diagnostic ultrasound option for retail clinics, urgent care centers, mini-hospitals, home healthcare providers, and rural and third-world regions where cost, space and mobility requirements had previously put traditional ultrasound out of reach.

For more information: www.healcerion.com

Related Content

DrChrono and 3D4Medical Partner to Bring 3-D Interactive Modeling to Physician Practices
News | Advanced Visualization | March 18, 2019
DrChrono Inc. and 3D4Medical have teamed up so practices across the United States can access 3-D interactive modeling...
Bay Labs Announces New Data on EchoGPS, AutoEF AI Software at ACC.19
News | Cardiovascular Ultrasound | March 15, 2019
Artificial intelligence (AI) company Bay Labs announced the presentation of two studies assessing performance of the...
Esaote Introduces MyLab X8 Ultrasound Platform
News | Ultrasound Imaging | March 13, 2019
Esaote announced the launch of MyLab X8, a high-performance, versatile ultrasound platform to support hospitals and...
Ultrasound Societies Urge FDA to Remove "Black Box" on Ultrasound Contrast Agents
News | Ultrasound Imaging | March 07, 2019
National and international ultrasound societies are urging the U.S. Food and Drug Administration to remove the “black...
Canon Medical Systems introduces 33 MHz Ultra-High Frequency Ultrasound Transducer
News | Ultrasound Imaging | March 01, 2019
March 1, 2019 — Expanding its advanced, high-performing Aplio i-series...
ACR Helping Radiologists Avoid Massive Ultrasound Reimbursement Cuts
News | Ultrasound Imaging | February 27, 2019
The American College of Radiology (ACR) urges radiologists and allied professionals to help the college ward off $112...
Fujifilm Exhibits Enterprise Imaging Solutions and Artificial Intelligence Initiative at HIMSS 2019
News | Enterprise Imaging | February 15, 2019
Fujifilm Medical Systems U.S.A. Inc. and Fujifilm SonoSite Inc. showcased their enterprise imaging and informatics...
Survey Finds Personalized Patient Engagement Improving But Still Lacking
News | Patient Engagement | February 12, 2019
Software company Pegasystems Inc. announced new survey data revealing the positive impact of quality patient engagement...
Micro-Ultrasound and Artificial Intelligence Combining to Detect Prostate Cancer
News | Prostate Cancer | February 12, 2019
Cambridge Consultants has partnered with Exact Imaging, makers of the ExactVu micro-ultrasound platform, as the two...
An example of Philips' TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal.

An example of Philips' TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal. 

Feature | Ultrasound Imaging | February 07, 2019 | Dave Fornell, Editor
Here is a list of six key trends in ul...